OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY

Pharmagreen Biotech Inc.

CIK 0001435181Ticker PHBISEC observed OTC

Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.

Open issuer dossier
Reporting & material events50

captured official filings

Registration & offering9

captured official filings

Ownership0

captured official filings

Governance0

captured official filings

WHAT THIS AUTOMATES

One evidence index instead of a manual filing hunt.

It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.

PROFESSIONAL DELIVERY LAYER

What teams can pay to automate next.

Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.

MACHINE-DETECTED FILING CHANGE RADAR

Public registration text delta

Comparing S-1 filed 2020-05-08 with S-1/A filed 2019-06-24.

Earlier SEC filingLatest SEC filing
487latest comparable sentences
233new-text candidates
258prior-text candidates not found

Tracked-term count changes

Counts are navigation signals, not conclusions. Open both official filings to determine materiality.

  • shares142 → 94-48
  • offering31 → 61+30
  • dilution6 → 11+5
  • management30 → 35+5
  • proceeds21 → 24+3
  • control30 → 33+3

Candidate disclosure excerpts

Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.

New in latest filing
  • The offering price has been arbitrarily determined by Pharmagreen Biotech Inc. and bears no relationship to assets, earnings, or any other valuation criteria.
  • PROSPECTUS PHARMAGREEN BIOTECH INC. 24,051,725 Shares 4,051,725 Common Stock Prior to this registration, Pharmagreen Biotech Inc. ("Pharmagreen", the "Company", "us", "we", "our") is presently traded on OTC Markets under the symbol PHBI.
  • We are offering up to 20,000,000 shares of common stock for sale by us to the public and registering for resale 4,051,725 shares of common stock held by existing shareholders.
Present in earlier filing, not found in latest
  • In the event of stock splits, stock dividends, or similar transactions involving the common stock, the number of common shares registered shall, unless otherwise expressly provided, automatically be deemed to cover the additional securities to be offered or issued pursuant to Rule 416 promulgated under the Securities Act of 1933
  • We are not selling any common stock under this registration statement and will not receive any of the proceeds from the sale of shares by the Selling Security Holders.
  • We will, however, receive proceeds from the sale of any shares that we put to Oscaleta under the Equity Purchase Agreement.

Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.

DOWNLOAD EDITION

Save a project-ready issuer record.

US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.

  • Source-linked filing chronology and registration path
  • Machine-detected amendment and tracked-term change view
  • Official-source index for project-file archiving and downloadable CSV export

Secure checkout by PayPal.

AUTOMATED EVIDENCE SNAPSHOT

Save this source-linked record

Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.

Unlock download · US$29
OFFICIAL SEC SUBMISSIONS

Captured filing chronology

Open Evidence Snapshot →
  1. 10-Q
    Reporting & material eventsOpen SEC filing →
  2. 10-Q
    Reporting & material eventsOpen SEC filing →
  3. 8-K
    Reporting & material eventsOpen SEC filing →
  4. 10-Q
    Reporting & material eventsOpen SEC filing →
  5. 10-K
    Reporting & material eventsOpen SEC filing →
  6. 8-K
    Reporting & material eventsOpen SEC filing →
  7. 10-Q
    Reporting & material eventsOpen SEC filing →
  8. 8-K
    Reporting & material eventsOpen SEC filing →
  9. 10-Q
    Reporting & material eventsOpen SEC filing →
  10. 10-Q
    Reporting & material eventsOpen SEC filing →
  11. 10-K
    Reporting & material eventsOpen SEC filing →
  12. 8-K
    Reporting & material eventsOpen SEC filing →
  13. 10-Q
    Reporting & material eventsOpen SEC filing →
  14. 8-K
    Reporting & material eventsOpen SEC filing →
  15. 10-K/A
    Reporting & material eventsOpen SEC filing →
  16. 10-Q
    Reporting & material eventsOpen SEC filing →
  17. 8-K
    Reporting & material eventsOpen SEC filing →
  18. 8-K
    Reporting & material eventsOpen SEC filing →
  19. 10-Q/A
    Reporting & material eventsOpen SEC filing →
  20. 10-Q
    Reporting & material eventsOpen SEC filing →
  21. 10-K
    Reporting & material eventsOpen SEC filing →
  22. 8-K
    Reporting & material eventsOpen SEC filing →
  23. 8-K
    Reporting & material eventsOpen SEC filing →
  24. 10-Q
    Reporting & material eventsOpen SEC filing →
  25. 8-K
    Reporting & material eventsOpen SEC filing →
  26. 8-K
    Reporting & material eventsOpen SEC filing →
  27. 8-K
    Reporting & material eventsOpen SEC filing →
  28. 10-Q
    Reporting & material eventsOpen SEC filing →
  29. S-1
    Registration & offeringOpen SEC filing →
  30. 8-K
    Reporting & material eventsOpen SEC filing →
  31. 10-Q
    Reporting & material eventsOpen SEC filing →
  32. 8-K
    Reporting & material eventsOpen SEC filing →
  33. 10-K
    Reporting & material eventsOpen SEC filing →
  34. 8-K
    Reporting & material eventsOpen SEC filing →
  35. 8-K
    Reporting & material eventsOpen SEC filing →
  36. 8-K
    Reporting & material eventsOpen SEC filing →
  37. 10-Q/A
    Reporting & material eventsOpen SEC filing →
  38. 10-Q
    Reporting & material eventsOpen SEC filing →
  39. EFFECT
    Registration & offeringOpen SEC filing →
  40. S-1/A
    Registration & offeringOpen SEC filing →
  41. S-1/A
    Registration & offeringOpen SEC filing →
  42. S-1/A
    Registration & offeringOpen SEC filing →
  43. S-1/A
    Registration & offeringOpen SEC filing →
  44. S-1
    Registration & offeringOpen SEC filing →
  45. 8-K
    Reporting & material eventsOpen SEC filing →
  46. 10-Q
    Reporting & material eventsOpen SEC filing →
  47. 8-K/A
    Reporting & material eventsOpen SEC filing →
  48. 8-K/A
    Reporting & material eventsOpen SEC filing →
  49. 10-K
    Reporting & material eventsOpen SEC filing →
  50. 8-K
    Reporting & material eventsOpen SEC filing →
  51. 10-Q
    Reporting & material eventsOpen SEC filing →
  52. 8-K
    Reporting & material eventsOpen SEC filing →
  53. 8-K
    Reporting & material eventsOpen SEC filing →
  54. 10-Q
    Reporting & material eventsOpen SEC filing →
  55. 8-K
    Reporting & material eventsOpen SEC filing →
  56. 10-Q
    Reporting & material eventsOpen SEC filing →
  57. 8-K
    Reporting & material eventsOpen SEC filing →
  58. EFFECT
    Registration & offeringOpen SEC filing →
  59. S-1
    Registration & offeringOpen SEC filing →
Evidence boundary

Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.